In distinction, in the same calendar year Merck documented Intercontinental pre-tax cash flow of more than $12 billion on roughly $27 billion in gross sales. This substantial discrepancy concerning Merck’s domestic and Global pre-tax cash flow seems to become the result of Merck’s use of